LATEST NEWS: FDA probes cognitive impact of new cholesterol drugs - (Reuters) - The Food and Drug Administration has asked Regeneron Pharmaceuticals Inc and Sanofi SA to assess potential neurocognitive side effects of their experimental cholesterol drug, Sanofi said in its annual report on Friday.
LATEST NEWS: U.S. deadly pig virus cases on the rise - (Reuters) - Cases of the deadly Porcine Epidemic Diarrhea virus, a highly contagious pig disease, are increasing across the U.S. farm belt, a group of animal health researchers said.
LATEST NEWS: Study ties troubled sleep to lower brain volume - NEW YORK (Reuters Health) - People who have trouble sleeping tend to have less volume in certain regions of the brain than those without sleep problems, a new study of Persian Gulf War veterans suggests.
LATEST NEWS: New hemophilia drugs aim to simplify treatment - LOS ANGELES (Reuters) - For 33-year-old video editor and hemophilia patient Travis Roop, being able to get life-saving infusions of a blood clotting agent every two weeks, instead of rushing to treat a bleeding episode, meant he could jog for the first time.
LATEST NEWS: Nurse numbers, education linked to patient death rate - NEW YORK (Reuters) - Both the quality and quantity of nurses on a hospital staff have significant influence on the chances patients will die following even simple surgery, according to a large new study.
LATEST NEWS: Panel recommends Northwest Bio brain-cancer trial continue - (Reuters) - Northwest Biotherapeutics Inc on Friday said an independent monitoring board had recommended that a late-stage study of its experimental brain-cancer treatment be continued, based on an interim safety review.